CLINICAL_TRIALS
trial_result
· 2016-11-22
Clinical Trial Update: Ticagrelor for PCI Post Thrombolysis [Phase 3]
Summary
Phase 3 trial evaluating ticagrelor for patients undergoing PCI after thrombolysis for acute myocardial infarction has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Unity Health Toronto | Conditions: Acute Myocardial Infarction | Phase 3 | Status: COMPLETED